专利检索 ap:("The Asan Foundation" OR "Daegu-Gyeongbuk Medical Innovation Foundation" OR "University Of Ulsan Foundation For Industry Cooperation") AND inv:"HWANG, Jung Jin" 第 1 页

1.

发明公开
QUINAZOLINE-2,4-DIAMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT 审中-公开

公开(公告)号：EP4230624A1

公开(公告)日：2023-08-23

申请号：EP21869736.5

申请日：2021-09-16

申请人： The Asan Foundation , Daegu-Gyeongbuk Medical Innovation Foundation , University Of Ulsan Foundation For Industry Cooperation

发明人： HWANG, Jung Jin , PARK, Sang Eun , KIM, Dong Eun , HONG, Ji-Ye , KIM, Choung-Soo , SON, Woo Chan , KIM, Shinae , KWON, Sugyeong , JUNG, Kyungjin , KIM, Nayeon , KIM, Jina , KIM, Kyung-Hee , CHIN, Jung Wook , CHO, Sung Jin , LEE, Sehan , CHA, Eunju , JOO, Jeongmin , HWANG, Ji Sun , PARK, Jeong-Eun , YU, Ji Hoon , HONG, Eunmi , PARK, Young-Hoon , LEE, Ju-Hee

IPC分类号： C07D401/14 , A61K31/517 , A61K31/5377 , A61K31/55 , A61P35/00 , C07D401/12 , A23L33/10

摘要： A compound, a stereoisomer thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof, provided as one aspect of the present invention, exhibits a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2), and thus, the compound can be usefully used for the treatment of cancer.